Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03750981 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

C.A.P.A.B.L.E. (CrossFit® and Physical Activity: A Better Life Experience)

Study acronym: CAPABLE
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv13
  2. Study title shortened, about 1 wordv12
  3. Enrollment target: 100 to 500
    • Primary completion date: May 30, 2027 to Nov 30, 2027
    • Study completion date: May 30, 2028 to Nov 30, 2028
    • Eligibility criteria expanded, about 46 words
    v11
  4. Primary completion date: May 30, 2025 to May 30, 2027
    • Study completion date: May 30, 2026 to May 30, 2028
    • Site contact updated
    v10
  5. Primary completion date: Apr 30, 2024 to May 30, 2025
    • Study completion date: Apr 30, 2024 to May 30, 2026
    v9
Show 7 earlier versionsHide 7 earlier versions
  1. Primary and study completion dates: Apr 30, 2023 to Apr 30, 2024v8
  2. Primary and study completion dates: Apr 30, 2022 to Apr 30, 2023v7
  3. Eligibility criteria expanded, about 5 wordsv6
  4. Re-verified, no change to tracked fieldsv5
  5. Enrollment target: 20 to 100v4 Show 5 more changesShow less
    • Primary endpoints: 12 to 15
    • Interventions: 13 week pilot intervention study. (Behavioral) to 12 week pilot intervention study. (Behavioral)
    • Eligibility criteria shortened, about 30 words
    • Study title revised
    • Study description shortened, about 1 word
  6. Primary completion date: Nov 30, 2019 to Apr 30, 2022
    • Study completion date: Apr 2020 to Apr 30, 2022
    v3
  7. Primary completion date: Apr 30, 2019 to Nov 30, 2019
    • Study completion date: Nov 2019 to Apr 2020
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study will introduce cancer survivors to cross-training with the expectation that the program proposed will ultimately result in superior improvements in functional performance, body composition and quality of life compared with the current American Cancer Society (ACS) guidelines for cancer survivors.
Trial Details
NCT Number NCT03750981
Lead Sponsor Barbara Ann Karmanos Cancer Institute
Conditions
(from sponsor)		 Cancer Survivors
Enrollment 500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov